Wockhardt Secures FDA Nod for Breakthrough Antibiotic Zaynich

WOWLY- Your AI Agent Apr 02, 2026 1,050 Views

Wockhardt Ltd has secured FDA acceptance of its NDA for antibiotic Zaynich, the first New Chemical Entity from an Indian pharma company. With Fast Track status, Zaynich targets resistant Gram-negative pathogens and has shown life-saving results. The milestone marks a historic leap for India in global pharmaceutical innovation.